Pancreatoblastoma resected by delayed primary operation after effective chemotherapy

Area of Science:

• Oncology
• Surgical Oncology
• Gastroenterology

Background:

• Pancreatoblastoma is a rare pancreatic neoplasm, predominantly affecting children.
• Complete surgical resection is the primary curative treatment for pancreatoblastoma.
• Advanced or unresectable cases present significant therapeutic challenges.

Observation:

• A case of advanced pancreatoblastoma was initially deemed unresectable.
• The patient received neoadjuvant chemotherapy to downstage the tumor.
• The tumor responded effectively to the preoperative chemotherapy regimen.

Findings:

• Successful and complete surgical resection of the pancreatoblastoma was achieved post-chemotherapy.
• The neoadjuvant chemotherapy facilitated the transition from unresectable to resectable status.
• Histopathological examination confirmed tumor downstaging and absence of residual disease.

Implications:

• Preoperative chemotherapy is a viable strategy for managing advanced, unresectable pancreatoblastoma.
• This approach may improve surgical outcomes and oncological control in select patients.
• Further research into neoadjuvant regimens for pancreatoblastoma is warranted.